Below are the financial statements of Bio Rad Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net sales | 2,566.5a | 2,671.2a | 2,802.2a |
| Cost of goods sold | -1,187.6a | -1,244.3a | -1,234.9a |
| Gross profit | 1,378.9a | 1,426.9a | 1,567.3a |
| Selling, general and administrative expense | -814a | -841.7a | -827.8a |
| Research and development expense | -295.9a | -247.4a | -256.9a |
| Income from operations | 269a | 337.8a | 482.6a |
| Interest expense | -48.9a | -49.4a | -38.1a |
| Foreign currency exchange gains, net | -3.9a | -7.3a | -0.2a |
| Losses from change in fair market value of equity securities and loan receivable | -2,656.8a | -1,252.3a | -5,193.6a |
| Other income, net | -90.3a | -106.5a | -44.7a |
| Net loss before income taxes | -2,342.5a | -850.1a | -4,704.2a |
| Benefit from income taxes | 498.3a | 212.8a | 1,076.7a |
| Net loss | -1,844.2a | -637.3a | -3,627.5a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.